home / stock / egrx / egrx articles

EGRX Articles, Eagle Pharmaceuticals Inc. - From 12/21/23

Stock Information
Company Name: Eagle Pharmaceuticals Inc.
Stock Symbol: EGRX
Market: NASDAQ
Website: eagleus.com
Menu
EGRX EGRX Quote EGRX Short EGRX News EGRX Articles EGRX Message Board
Get EGRX Alerts

News, Short Squeeze, Breakout and More Instantly...
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc. (EGRX) Investors of a Class Action Lawsuit and Upcoming Deadline | Benzinga

NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceutic...
DEADLINE ALERT for GM, EGRX, and MRCY: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders | Benzinga

LOS ANGELES, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on ...

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – EGRX | Benzinga

NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securiti...

EAGLE PHARMACEUTICALS ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options | Benzing

If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and wou...
EGRX Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Eagle Pharmaceuticals, Inc. Class Action | Benzinga

SAN DIEGO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and...

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX) | Benzinga

LOS ANGELES, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming February 9, 2024 deadl...

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc.(EGRX) Investors of a Class Action Lawsuit and Upcoming Deadline | Benzinga

NEW YORK, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceutic...
EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eagle Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm | Benzinga

NEW YORK, Dec. 17, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds invest...

Kaplan Fox & Kilsheimer LLP Reminds Eagle Pharmaceuticals Investors of a Class Action and Upcoming Deadline | Benzinga

NEW YORK, Dec. 17, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of inves...

DEADLINE ALERT for EH and EGRX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders | Benzinga

LOS ANGELES, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on ...
Previous 10 Next 10